News Conference News TCT 2021 Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown Michael O'Riordan October 07, 2021
News Daily News SWEDEHEART Data Reassure on 10-Year Survival for TAVI Patients With Pacemakers Caitlin E. Cox October 05, 2021
News Daily News FDA Approves Portico TAVI Valve, Paving the Way for Third US Device Shelley Wood September 20, 2021
News Daily News Valve-in-Valve TAVI Bests Redo SAVR in Short Term Michael O'Riordan September 20, 2021
News Daily News With Some Adjustments, Commissural Alignment Possible With TAVI Michael O'Riordan September 16, 2021
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Conference News TVT 2021 TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year Todd Neale July 20, 2021
News Daily News Be ‘Mindful’ of TAVI Unknowns in Younger Patients, Experts Urge Caitlin E. Cox June 09, 2021
News Conference News EuroPCR 2021 Good TAVI Results Seen in Bicuspid Aortic Stenosis: TVT Registry Todd Neale May 20, 2021
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021
News Daily News TAVI Matches SAVR in Older US Patients With Rheumatic Aortic Stenosis Caitlin E. Cox April 05, 2021
News Conference News CRT 2021 Low Mortality and Stroke Rates With BASILICA Pre-TAVI, Registry Shows Michael O'Riordan March 09, 2021
News Daily News TAVR Yields Similar Success in Failed TAVR or Surgical Valves Caitlin E. Cox January 07, 2021
News Daily News New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR Caitlin E. Cox December 23, 2020
News Daily News Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut Michael O'Riordan October 28, 2020
Presentation TCT 2020 SOLVE TAV - A 2x2 Randomized Trial of Self-Expandable vs Balloon-Expandable Valves and General vs Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Implantation: 1-year Results Presenter: Hans-Josef Feistritzer October 16, 2020
Presentation TCT 2020 A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial Presenter: Jeffrey W. Moses October 15, 2020